Vident Advisory LLC Has $710,000 Stake in Chemed Co. (NYSE:CHE)

Vident Advisory LLC increased its holdings in shares of Chemed Co. (NYSE:CHE - Free Report) by 112.4% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 1,340 shares of the company's stock after acquiring an additional 709 shares during the period. Vident Advisory LLC's holdings in Chemed were worth $710,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the business. CIBC Asset Management Inc grew its holdings in Chemed by 5.1% in the fourth quarter. CIBC Asset Management Inc now owns 457 shares of the company's stock valued at $242,000 after purchasing an additional 22 shares during the last quarter. CBIZ Investment Advisory Services LLC grew its holdings in Chemed by 64.7% in the fourth quarter. CBIZ Investment Advisory Services LLC now owns 56 shares of the company's stock valued at $30,000 after purchasing an additional 22 shares during the last quarter. CIBC Private Wealth Group LLC grew its holdings in Chemed by 13.5% in the fourth quarter. CIBC Private Wealth Group LLC now owns 185 shares of the company's stock valued at $98,000 after purchasing an additional 22 shares during the last quarter. Independent Advisor Alliance grew its holdings in Chemed by 1.1% in the fourth quarter. Independent Advisor Alliance now owns 2,279 shares of the company's stock valued at $1,207,000 after purchasing an additional 25 shares during the last quarter. Finally, EverSource Wealth Advisors LLC grew its holdings in Chemed by 7.1% in the fourth quarter. EverSource Wealth Advisors LLC now owns 498 shares of the company's stock valued at $264,000 after purchasing an additional 33 shares during the last quarter. Institutional investors and hedge funds own 95.85% of the company's stock.

Insider Activity

In related news, CEO Kevin J. Mcnamara sold 1,000 shares of the company's stock in a transaction on Monday, March 31st. The stock was sold at an average price of $615.33, for a total transaction of $615,330.00. Following the transaction, the chief executive officer now directly owns 101,679 shares of the company's stock, valued at approximately $62,566,139.07. The trade was a 0.97% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, EVP Spencer S. Lee sold 1,500 shares of the company's stock in a transaction dated Friday, May 16th. The stock was sold at an average price of $577.99, for a total value of $866,985.00. Following the completion of the transaction, the executive vice president now directly owns 14,627 shares in the company, valued at approximately $8,454,259.73. The trade was a 9.30% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 7,500 shares of company stock worth $4,401,120 over the last 90 days. 3.29% of the stock is currently owned by company insiders.

Wall Street Analyst Weigh In

A number of research firms recently commented on CHE. Royal Bank of Canada increased their price objective on Chemed from $667.00 to $674.00 and gave the company an "outperform" rating in a research note on Monday, April 28th. Wall Street Zen raised Chemed from a "hold" rating to a "buy" rating in a research note on Friday, March 7th.

Chemed Trading Up 0.1%

Shares of Chemed stock traded up $0.49 during trading hours on Friday, reaching $573.68. The stock had a trading volume of 7,904 shares, compared to its average volume of 102,841. The firm has a 50 day simple moving average of $581.34 and a two-hundred day simple moving average of $565.81. The firm has a market capitalization of $8.39 billion, a price-to-earnings ratio of 28.98, a P/E/G ratio of 2.15 and a beta of 0.59. Chemed Co. has a 1 year low of $512.12 and a 1 year high of $623.61.

Chemed (NYSE:CHE - Get Free Report) last released its quarterly earnings data on Wednesday, April 23rd. The company reported $5.63 EPS for the quarter, topping analysts' consensus estimates of $5.59 by $0.04. Chemed had a return on equity of 27.86% and a net margin of 12.69%. The company had revenue of $646.94 million for the quarter, compared to the consensus estimate of $641.78 million. During the same period last year, the business posted $5.20 EPS. The company's quarterly revenue was up 9.8% compared to the same quarter last year. Sell-side analysts forecast that Chemed Co. will post 21.43 EPS for the current year.

Chemed Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 17th. Stockholders of record on Thursday, May 29th will be issued a $0.50 dividend. The ex-dividend date is Thursday, May 29th. This represents a $2.00 annualized dividend and a dividend yield of 0.35%. Chemed's dividend payout ratio (DPR) is 9.74%.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.